Abstract
Profound metabolic differences between cancer cells and fibroblasts promote tumorigenesis. A study by Valencia and colleagues in this issue of Cancer Cell supports this assertion. They observed that metabolic asymmetry in prostate tumors drives aggressive disease with high p62 in anabolic cancer cells, but loss of p62 in catabolic fibroblasts.
| Original language | English |
|---|---|
| Journal | Cancer Cell |
| Volume | 26 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 14 Jul 2014 |